USA flag logo/image

An Official Website of the United States Government

BLUE LED LIGHT PANEL FOR TREATMENT OF WINTER DEPRESSION

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
61101
Program Year/Program:
2002 / SBIR
Agency Tracking Number:
MH066453
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
APOLLO LIGHT SYSTEMS, INC.
947 South 500 East Suite 210 American Fork, UT 84003 4003
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2002
Title: BLUE LED LIGHT PANEL FOR TREATMENT OF WINTER DEPRESSION
Agency: HHS
Contract: 1R43MH066453-01
Award Amount: $109,818.00
 

Abstract:

DESCRIPTION (provided by applicant): Multiple studies have established that bright light therapy is effective in alleviating symptoms of winter depression (seasonal affective disorder, or SAD). Light units used for treating SAD in the past have generally emitted polychromatic white light of highly variable spectral properties. Although several studies have attempted to test the effectiveness of specific wavelengths of red, blue and green light for treatment of SAD, the devices used in those studies employed relatively broad bandwidths of light. With the technological advancements in light emitting diodes (LEDs), the production of new light treatment equipment with much narrower bandwidths of light is possible. A recently completed action spectrum demonstrated that 446-477 nm is the most potent wavelength range for regulating melatonin secretion. These results suggest that a novel opsin photopigment, separate from the four classical visual opsins, mediates the effects of light on melatonin and raises the possibility that light treatment for SAD may share a common photoreceptor system and therefore, a similar spectral sensitivity. The specific aims of this proposed study are to: 1) produce an LED panel light box which emits narrow band light stimuli with a 470 nm peak (30 nm half-peak bandwidth) for light treatment of SAD; 2) confirm safety of this device through a hazard analysis based on accepted federal and industrial guidelines, and 3) use this device to test the hypothesis that light stimuli concentrated in the 470 nm range is therapeutically effective in treating SAD. Therapeutic efficacy will be tested in a double-blind, randomized cross-over study design comparing a narrow band LED light source with a spectral peak at 470 nm (30 nm half-peak bandwidth) to a narrow band dim red light placebo control with peak emission at 700 nm. Demonstration of efficacy of relatively narrow bandwidth blue light will pave the way for future studies in which this spectral range may be further tested for SAD treatment and circadian rhythm dysfunctions in order to maximize therapeutic benefits with lower light intensities and therefore, fewer side effects.

Principal Investigator:

Henry C. Savage
8012262370
KENT@APOLLOLIGHT.COM

Business Contact:

Henry Savage jr
8012262370
KENT@APOLLOLINGHT.COM
Small Business Information at Submission:

APOLLO LIGHT SYSTEMS, INC.
APOLLO LIGHT SYSTEMS, INC. 352 WEST 1060 SOUTH OREM, UT 84058

EIN/Tax ID: 870460727
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No